RNSCLC-PRSP software to predict the prognostic risk and survival in patients with resected T1-3N0–2 M0 non-small cell lung cancer

被引：0
|
作者：
Yunkui Zhang
YaoChen Li
Rongsheng Zhang
Yujie Zhang
Haitao Ma
机构：
[1] The First Affiliated Hospital of Soochow University,Department of Thoracic Surgery
[2] Shanxi Tumor Hospital,Department of Thoracic Surgery
[3] Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research,The Central Laboratory of Cancer Hospital of Shantou University Medical College
来源：
BioData Mining | / 12卷
关键词：
Resected non-small cell lung cancer; Prognostic risk prediction; Survival prediction; Prognostic index; Software;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Stereotactic ablative radiotherapy ( SABR) for non-small cell lung cancer (NSCLC): analysis of T3N0M0 patients
    Pickles, R.
    Atherton, P.
    Turnbull, H.
    Burns, A.
    Iqbal, M. S.
    [J]. LUNG CANCER, 2020, 139 : S31 - S31
  • [32] Survival Outcomes in Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer: Wedge Resection or Segmentectomy
    Kobayashi, Aki
    Ishikawa, Renta
    Takao, Motoshi
    Shimamoto, Akira
    Ito, Atsushi
    Shimpo, Hideto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S301 - S302
  • [33] Lobectomy or wedge resection? - The comparison of outcome in patients operated on for T1N0M0 non-small cell lung cancer
    Bella, Mariusz
    Kowalewski, Janusz
    Dancewicz, Maciej
    Swiniarska, Joanna
    Malinowski, Wojciech
    [J]. KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2007, 4 (04): : 397 - 401
  • [34] Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)
    Zimmermann, Frank B.
    Geinitz, Hans
    Schill, Sabine
    Thamm, Reinhard
    Nieder, Carsten
    Schratzenstaller, Ulrich
    Molls, Michael
    [J]. ACTA ONCOLOGICA, 2006, 45 (07) : 796 - 801
  • [35] Prognostic impact of lymph node ratio in patients with pT1-2N1M0 non-small cell lung cancer
    Shin, Sumin
    Kang, Danbee
    Cho, Jong Ho
    Choi, Yong Soo
    Kim, Jhingook
    Zo, Jae Ill
    Shim, Young Mog
    Kim, Hong Kwan
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5552 - +
  • [36] Postresection irradiation for T2 N0 M0 non-small cell carcinoma: A prospective, randomized study
    Lafitte, JJ
    Ribet, ME
    Prevost, BM
    Gosselin, BH
    Copin, MC
    Brichet, AH
    [J]. ANNALS OF THORACIC SURGERY, 1996, 62 (03): : 830 - 834
  • [37] A randomised trial of radical radiotherapy with or without low dose gemcitabine in medically inoperable patients with T1-2 N0-1 M0 non-small cell lung cancer (NSCLC)
    Price, Allan
    Yellowlees, Ann
    Faivre-Finn, Corinne
    Gilligan, David
    Snee, Michael
    Erridge, Sara
    Mohammed, Nazia
    Russell, Susan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S587 - S587
  • [38] Is there a prognostic difference among patients with T3N0-3M0 non-small-cell lung cancer with different T3 descriptors?
    Cai, Jing-Sheng
    Yang, Fan
    Wang, Xun
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2023, 63 (03)
  • [39] Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer
    Landreneau, RJ
    Sugarbaker, DJ
    Mack, MJ
    Hazelrigg, SR
    Luketich, JD
    Fetterman, L
    Liptay, MJ
    Bartley, S
    Boley, TM
    Keenan, RJ
    Ferson, PF
    Weyant, RJ
    Naunheim, KS
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (04): : 691 - 700
  • [40] Is Primary Tumor Metabolic Activity a Risk Factor for Occult Lymph Node Metastasis in T1-2N0M0 Non-small Cell Lung Cancer Patients?
    Yildirim, Fatma
    Turk, Murat
    Akdemir, Umit Ozgur
    Tastepe, Abdullah Irfan
    Yurdakul, Ahmet Selim
    [J]. GAZI MEDICAL JOURNAL, 2016, 27 (02): : 71 - 75
12345